Abstract

Background and aimsThe itemization difference of patient-reported outcome (PRO) in hepatitis patients with different etiologies remains elusive in Asia. We aimed to assess the characteristics and the difference of health-related quality of life (HRQoL) in chronic hepatitis B (CHB), chronic hepatitis C (CHC), and non-alcoholic fatty liver disease (NAFLD) patients.MethodsWe conducted the study in an outpatient setting. The 36-Item Short Form Health Survey (SF-36) was completed by the patients upon the initial diagnosis and recruitment for a long-term follow-up purpose. The PRO results were also assessed by disease severity.ResultsThere were 244 patients (198 males) of CHB, 54 patients (29 males) of CHC, and 129 patients (85 males) of NAFLD, respectively. CHC patient had the mean score of 67.1 ± 23.3 in physical component summary (PCS) of the SF-36 health survey, which was significantly lower than CHB patients (76.4 ± 19.5), and NAFLD patients (77.5 ± 13.7), respectively (p = 0.001). The significantly lower performance of PCS in CHC patients was mainly attributed to the lower performance in physical functioning and bodily pain components. Higher fibrosis 4 index scores were significantly associated with lower PCS scores in all patient groups. There was no significant difference of mean mental component summary (MCS) between groups. However, NAFLD patients had significantly lower mental health scores than other groups (p = 0.02).ConclusionsThe significant difference of HRQoL exists in hepatitis patients with different etiologies. Disease severity leads to a lower PCS performance.

Highlights

  • Hepatitis is a worldwide huge health concern, largely due to its subsequent sequela such as cirrhosis, liver failure and hepatocellular carcinoma (HCC)

  • chronic hepatitis C (CHC) patient had the mean score of 67.1 ± 23.3 in physical component summary (PCS) of the social functioning (SF)-36 health survey, which was significantly lower than chronic hepatitis B (CHB) patients (76.4 ± 19.5), and non-alcoholic fatty liver disease (NAFLD) patients (77.5 ± 13.7), respectively (p = 0.001)

  • Higher fibrosis 4 index scores were significantly associated with lower PCS scores in all patient groups

Read more

Summary

Introduction

Hepatitis is a worldwide huge health concern, largely due to its subsequent sequela such as cirrhosis, liver failure and hepatocellular carcinoma (HCC). The causes and/or etiologies vary in different regions globally. Mainly hepatitis B virus (HBV) and C virus (HCV), are prevalent in Asia-Pacific region. The rapid progress of therapeutic and diagnostic strategies in viral hepatitis infections has largely changed the landscape of management [1]. The accumulated health burden of viral hepatitis infections has been significantly exacerbated by a global increase of non-alcoholic fatty liver disease (NAFLD) in parallel to the global westernization [1,2,3,4]. The natural course and disease mechanisms in NAFLD as well as the optimal lifestyle intervention and therapeutic potentials remain elucidation. We aimed to assess the characteristics and the difference of health-related quality of life (HRQoL) in chronic hepatitis B (CHB), chronic hepatitis C (CHC), and non-alcoholic fatty liver disease (NAFLD) patients

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call